Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Clinical and translational medicine - 11(2021), 12 vom: 28. Dez., Seite e647 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qiu, Hangyuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Carrier Proteins |
---|
Anmerkungen: |
Date Completed 02.03.2022 Date Revised 02.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/ctm2.647 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM335008291 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM335008291 | ||
003 | DE-627 | ||
005 | 20231225224913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ctm2.647 |2 doi | |
028 | 5 | 2 | |a pubmed24n1116.xml |
035 | |a (DE-627)NLM335008291 | ||
035 | |a (NLM)34965010 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Qiu, Hangyuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.03.2022 | ||
500 | |a Date Revised 02.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Carrier Proteins |2 NLM | |
650 | 7 | |a HSC70 Heat-Shock Proteins |2 NLM | |
650 | 7 | |a myosin-binding protein C |2 NLM | |
700 | 1 | |a Sun, Yaxun |e verfasserin |4 aut | |
700 | 1 | |a Pan, Ziwei |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Jingjun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Hongkun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiaochen |e verfasserin |4 aut | |
700 | 1 | |a Cai, Dongsheng |e verfasserin |4 aut | |
700 | 1 | |a Fu, Guosheng |e verfasserin |4 aut | |
700 | 1 | |a Gong, Tingyu |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Chenyang |e verfasserin |4 aut | |
700 | 1 | |a Liang, Ping |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 11(2021), 12 vom: 28. Dez., Seite e647 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:12 |g day:28 |g month:12 |g pages:e647 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.647 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 12 |b 28 |c 12 |h e647 |